170 related articles for article (PubMed ID: 37439687)
1. Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels.
Zhao A; Wegener M; Brooks R; Mininberg L; Helou E; Maughan A; Villanueva M
Health Promot Pract; 2023 Sep; 24(5):1029-1038. PubMed ID: 37439687
[No Abstract] [Full Text] [Related]
2. Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods.
Brooks R; Wegener M; Speers S; Nichols L; Sideleau R; Valeriano T; Buchelli M; Villanueva M
Health Promot Pract; 2023 Sep; 24(5):1039-1049. PubMed ID: 37439600
[TBL] [Abstract][Full Text] [Related]
3. Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut.
Wegener M; Brooks R; Speers S; Nichols L; Villanueva M
Public Health Rep; 2024; 139(2):208-217. PubMed ID: 37232422
[TBL] [Abstract][Full Text] [Related]
4. The British HIV Association national clinical audit 2021: Management of HIV and hepatitis C coinfection.
Raya RP; Curtis H; Kulasegaram R; Cooke GS; Burns F; Chadwick D; Sabin CA;
HIV Med; 2023 Apr; 24(4):471-479. PubMed ID: 36172948
[TBL] [Abstract][Full Text] [Related]
5. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
[TBL] [Abstract][Full Text] [Related]
6. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010-2018.
Simoncini GM; Hou Q; Carlson K; Buchacz K; Tedaldi E; Palella F; Durham M; Li J;
AIDS Patient Care STDS; 2021 Oct; 35(10):392-400. PubMed ID: 34623891
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus micro-elimination within a clinic for people with HIV: challenges in the home stretch.
Hanna J; Sufian J; Suh JS; Jimenez HR
HIV Med; 2022 Aug; 23(7):801-806. PubMed ID: 35150183
[TBL] [Abstract][Full Text] [Related]
9. Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus.
Bar N; Bensoussan N; Rabinowich L; Levi S; Houri I; Ben-Ami Shor D; Shibolet O; Mor O; Weitzman E; Turner D; Katchman H
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429957
[TBL] [Abstract][Full Text] [Related]
10. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
[TBL] [Abstract][Full Text] [Related]
11. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
Zuckerman AD; Douglas A; Whelchel K; Choi L; DeClercq J; Chastain CA
PLoS One; 2019; 14(11):e0225434. PubMed ID: 31751399
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus treatment response to ledipasvir/sofosbuvir among patients coinfected with HIV and HCV: Real world data in a black population.
Banga J; Nizami S; Slim J; Nagarakanti S; Portilla M; Swaminathan S
Medicine (Baltimore); 2020 Mar; 99(11):e19140. PubMed ID: 32176039
[TBL] [Abstract][Full Text] [Related]
14. Effects of direct-acting antiviral treatment on reducing mortality among Medicare beneficiaries with HIV and HCV coinfection.
Yin X; Kong L; Du P; Jung J
AIDS Care; 2022 Oct; 34(10):1330-1337. PubMed ID: 34581640
[TBL] [Abstract][Full Text] [Related]
15. Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
Doyle JS; van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME
Clin Infect Dis; 2021 Oct; 73(7):e2164-e2172. PubMed ID: 33010149
[TBL] [Abstract][Full Text] [Related]
16. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
17. The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV.
Cachay ER; Torriani FJ; Hill L; Jain S; Del Real A; Qin H; Martin N; Mathews WC
AIDS; 2020 Sep; 34(11):1681-1683. PubMed ID: 32769765
[TBL] [Abstract][Full Text] [Related]
18. Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.
Allyn PR; O'Malley SM; Ferguson J; Tseng CH; Chew KW; Bhattacharya D
Int J STD AIDS; 2018 Mar; 29(4):334-340. PubMed ID: 28820346
[TBL] [Abstract][Full Text] [Related]
19. Management of acute and chronic HCV infection in persons with HIV coinfection.
Sulkowski MS
J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
[TBL] [Abstract][Full Text] [Related]
20. Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
Grebely J; Oser M; Taylor LE; Dore GJ
J Infect Dis; 2013 Mar; 207 Suppl 1(Suppl 1):S19-25. PubMed ID: 23390301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]